Council Members in this Study Group: 66
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
General Neurologist
MEDFORD NEUROLOGY![]()
Walter Carlini, MD, PhD, is a General Neurologist at the Medford Neurology Clinic in Oregon. Previously, Dr. Carlini was a General Neurologist at Medford Neurological and Spine Clinic. His clinical interests include stroke, epilepsy, migraine, dementia,...
Josef ParviziAssistant Professor of Neurology
Stanford University Medical Center![]()
Josef Parvizi, MD, PhD, is a board certified clinical neurologist with more than 15 years of clinical experience. Dr. Parvizi treats patients with various neurological disorders and teaches at Stanford University Medical School. He has published multiple...
Daniel WynnDirector, Clinical Research
CONSULTANTS IN NEUROLOGY LTD![]()
Daniel Wynn, MD, FACN, FAASM, is the Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 140 clinical trials in...
Founder and Director
Institute for Integrative Psychiatry![]()
Rami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between...
Leading Experts in Physicians who Treat Huntington's Disease (US) Study Group have not participated in any upcoming seminars.
View All GLG Live Meetings in Healthcare
Teleconference: Multiple Sclerosis - Novel Therapies Under Development (3:30 PM EST/12:30 PM PST)
12/2/2010